Name
Osaühing Perearst Katrin Akkel
Registry code
11445372
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
05.11.2007 (17)
Financial year
01.01-31.12
Capital
2 556.00 €
Activity
86211 - Provision of general medical treatment
199 558 €
82 190 €
41%
2 167 €
(estimate is approximate)
99 605 €
2
Submitted
No tax arrears
83%
80%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Katrin Akkel 03.12.1968 (55) | 100% - 2 556.00 EUR | Board member | Direct ownership | Founder |
| 2019 24.02.2020 | 2020 22.03.2021 | 2021 21.05.2022 | 2022 03.06.2023 | 2023 09.06.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 126 573 € | 125 645 € | 154 925 € | 193 627 € | 199 558 € |
| Net profit (loss) for the period | 56 223 € | 67 922 € | 77 821 € | 113 969 € | 82 190 € |
| Profit Margin | 44% | 54% | 50% | 59% | 41% |
| Current Assets | 61 738 € | 72 414 € | 83 607 € | 119 785 € | 102 130 € |
| Fixed Assets | - | - | - | - | - |
| Total Assets | 61 738 € | 72 414 € | 83 607 € | 119 785 € | 102 130 € |
| Current Liabilities | 2 703 € | 1 790 € | 3 162 € | 2 370 € | 2 525 € |
| Non Current Liabilities | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 59 035 € | 70 624 € | 80 445 € | 117 415 € | 99 605 € |
| Employees | 2 | 2 | 2 | 2 | 2 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | - | 6 978.05 € | 7 535 € | 4 |
| 2023 Q4 | - | 6 704.89 € | 7 278.57 € | 4 |
| 2023 Q3 | - | 6 230.02 € | 6 758.02 € | 4 |
| 2023 Q2 | - | 29 889.69 € | 11 258.05 € | 2 |
| 2023 Q1 | - | 4 771.32 € | 5 183.16 € | 3 |
| 2022 Q4 | - | 3 136.8 € | 3 400.8 € | 3 |
| 2022 Q3 | - | 3 690.96 € | 4 001.6 € | 3 |
| 2022 Q2 | - | 22 631.63 € | 10 387.94 € | 3 |
| 2022 Q1 | - | 3 663.84 € | 3 922.91 € | 3 |
| 2021 Q4 | - | 3 221.61 € | 3 505.28 € | 2 |
| 2021 Q3 | - | 19 742.61 € | 7 710.82 € | 2 |
| 2021 Q2 | - | 3 612.95 € | 3 946.01 € | 3 |
| 2021 Q1 | - | 3 368.11 € | 3 668.41 € | 3 |
| 2020 Q4 | - | 15 976.47 € | 5 116.52 € | 2 |
| 2020 Q3 | - | 1 716.24 € | 1 867.95 € | 2 |
| 2020 Q2 | - | 1 568.4 € | 1 700.4 € | 1 |
| 2020 Q1 | - | 1 621.73 € | 1 758.22 € | 1 |
